YMU1
Product Specifications
UNSPSC Description
YMU1 is a selective inhibitor of human thymidylate kinase (hTMPK) with an IC50 of 610 nM. YMU1 inhibits tumor proliferation[1][2].
Target Antigen
Others; STAT
Type
Reference compound
Related Pathways
JAK/STAT Signaling;Others;Stem Cell/Wnt
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ymu1.html
Purity
99.00
Solubility
DMSO : 5.56 mg/mL (ultrasonic;warming;heat to 70°C)
Smiles
O=C(N1CCN(C(CN2SC3=NC(C)=CC(C)=C3C2=O)=O)CC1)OCC
Molecular Weight
378.45
References & Citations
[1]Hu CM, et al. Tumor cells require thymidylate kinase to prevent dUTP incorporation during DNA repair. Cancer Cell. 2012 Jul 10;22(1):36-50.|[2]Fengqiang Yu, et al. Knockdown of DTYMK suppresses progression and EMT of lung adenocarcinoma 1 via STAT3 signaling. Europe PMC. 20 Mar 2023, 55(5):213-221.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-129125/YMU1-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-129125/YMU1-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
902589-96-2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6178775-01 0.1 mL
MYO15A (Myosin XVA, DFNB3, DKFZp686N18198, FLJ17274, FLJ31311, MYO15) (FITC)
Ask
View Details MBS6178775-02 5x 0.1 mL
MYO15A (Myosin XVA, DFNB3, DKFZp686N18198, FLJ17274, FLJ31311, MYO15) (FITC)
Ask
View Details 
